Skip to content
10-K/A

Annual Report

enVVeno Medical Corp NVNO

0001493152-25-008739

← back to feed
Filed
Feb 28, 2025 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 25, 2025 17.54M sh
Shares Diluted restated FY 2024 · Dec 31, 2024 17.14M sh
Shares Diluted FY 2024 · Dec 31, 2023 12.3M sh
Capex FY 2024 · Dec 31, 2024 $37K
Capex FY 2024 · Dec 31, 2023 $33K
Operating Cash Flow FY 2024 · Dec 31, 2024 −$16.84M
Operating Cash Flow FY 2024 · Dec 31, 2023 −$18.86M
Short Term Investments FY 2024 · Dec 31, 2024 $41.4M
Short Term Investments FY 2024 · Dec 31, 2023 $42.79M
Cash And Equivalents FY 2024 · Dec 31, 2024 $1.75M
Cash And Equivalents FY 2024 · Dec 31, 2023 $3.62M
Stockholders Equity FY 2024 · Dec 31, 2024 $42.16M
Stockholders Equity FY 2024 · Dec 31, 2023 $46.2M
Stockholders Equity FY 2024 · Dec 31, 2022 $38.73M
Current Liabilities FY 2024 · Dec 31, 2024 $2.1M
Current Liabilities FY 2024 · Dec 31, 2023 $1.37M
Total Liabilities FY 2024 · Dec 31, 2024 $2.8M
Total Liabilities FY 2024 · Dec 31, 2023 $2.44M
Current Assets FY 2024 · Dec 31, 2024 $43.73M
Current Assets FY 2024 · Dec 31, 2023 $46.92M
Total Assets FY 2024 · Dec 31, 2024 $44.95M
Total Assets FY 2024 · Dec 31, 2023 $48.64M
Eps Diluted restated FY 2024 · Dec 31, 2024 −$1.27
Eps Diluted FY 2024 · Dec 31, 2023 −$1.91
Eps Basic restated FY 2024 · Dec 31, 2024 −$1.27
Eps Basic FY 2024 · Dec 31, 2023 −$1.91
Sga Expense FY 2024 · Dec 31, 2024 $11.58M
Sga Expense FY 2024 · Dec 31, 2023 $11.66M
Rd Expense FY 2024 · Dec 31, 2024 $12.25M
Rd Expense FY 2024 · Dec 31, 2023 $13.58M
Net Income FY 2024 · Dec 31, 2024 −$21.82M
Net Income FY 2024 · Dec 31, 2023 −$23.52M
Operating Income FY 2024 · Dec 31, 2024 −$23.83M
Operating Income FY 2024 · Dec 31, 2023 −$25.24M